PARK2 is a bona fide haploinsufficient tumor suppressor, as depletion of a single PARK2 allele significantly increases adenoma development and polyp multiplicity in ApcMin/+ mice (Poulogiannis et al., 2010). The gene discussed is PRKN; the disease is neoplasm.